Novartis CEO believes Pharma growth in China will beat US & Europe

CHINA biotech

Joe Jimenez, CEO of Novartis, believes that pharmaceutical sales in China will continue to grow faster than in western markets. China has faced pressure due to its economic slowdown, but analysts believe pharma sales growth will still be significant. Novartis is set to open a global research and development facility in Shanghai at the cost of $1 billion.

Read the source article at FT.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>